Bevacizumab for the Treatment of High-Grade Meningiomas: Is There New Evidence? [Letter]

Abstract

Vinicius Trindade Gomes da Silva,1,2 Thiago Gebrin,1 Wellingson Silva Paiva1 1LIM 62, University of Sao Paulo Medical School, Sao Paulo, Brazil; 2AC Camargo Cancer Center, Sao Paulo, BrazilCorrespondence: Wellingson Silva Paiva, Division of Neurosurgery, University of Sao Paulo Medical School, Sao Paulo, 05403000, Brazil, Email [email protected]

Keywords

• bevacizumab
• meningiomas
• overall survival
• peritumoral brain edema
• progression-free survival.